20220426-招银国际-中兴通讯-00763.HK-Strong_1Q22_results__continuing_improvement_in_operation_and_business_development_4页_904kb
报告摘要
ZTE (763 HK) Company Update Summary
Core Content
ZTE (763 HK) released its 1Q22 results, which showed a strong performance with revenue and net profit to shareholders growing by 6.4% and 1.6% YoY, respectively, reaching RMB27.9bn and RMB2.2bn. These results were largely in line with expectations, and the firm maintains a BUY rating with an unchanged target price of HK$29.65.
Looking ahead, ZTE is expected to continue its business development and operational improvement. The company is projected to achieve 12.9% YoY revenue growth for FY22E and 15.7% YoY net profit growth. The firm is also anticipated to gain market share in the telecommunications sector as China's telecom operators increase their capex budget to RMB352bn for FY22E, a 4% YoY increase. Although 5G-related capex budgets have slightly decreased by 5%, the overall pace of 5G BTS deployment remains steady.
ZTE's share in telco capex is currently ~22.3%, and is expected to rise slightly to 22.8% in 2022. The firm is seen as a key beneficiary as the telco sector shifts investment from 5G infrastructure to industrial digitalization.
Main Points
-
1Q22 Performance:
- Revenue: RMB27.9bn (+6.4% YoY)
- Net Profit to Shareholders: RMB2.2bn (+1.6% YoY)
- GPM increased to 37.8% from 35.2% in FY21, driven by the telecom segment.
- NP before extraordinary items grew 117% YoY, indicating improved business operations.
-
Future Projections:
- FY22E revenue growth: 12.9% YoY
- FY22E net profit growth: 15.7% YoY
- Carrier revenue growth is expected to exceed telco capex growth (6.1% vs. 3.9%).
-
Market Outlook:
- ZTE is expected to benefit from the shift in telco investment from 5G to industrial digitalization.
- Current valuation is seen as attractive due to the broad market pullback and macroeconomic concerns.
Key Financial Metrics
Earnings Summary (RMB mn)
| Metric | FY20A | FY21A | FY22E | FY23E | FY24E |
|---|---|---|---|---|---|
| Revenue | 101,451 | 114,522 | 129,803 | 146,400 | 163,351 |
| Net Profit | 4,260 | 6,813 | 7,845 | 9,096 | 10,253 |
Earnings Growth (%)
| Metric | FY20A | FY21A | FY22E | FY23E | FY24E |
|---|---|---|---|---|---|
| Revenue Growth | 11.8% | 12.9% | 13.3% | 12.8% | 11.6% |
| Net Profit Growth | -17.3% | 59.9% | 15.1% | 15.9% | 12.7% |
Key Ratios
| Ratio | FY20A | FY21A | FY22E | FY23E | FY24E |
|---|---|---|---|---|---|
| Gross Margin (%) | 31.6% | 35.2% | 35.6% | 35.2% | 35.0% |
| Net Profit Margin (%) | 4.2% | 5.9% | 6.0% | 6.2% | 6.3% |
| ROE (%) | 9.8% | 13.2% | 13.4% | 13.7% | 13.5% |
| Current Ratio (x) | 1.4 | 1.6 | 1.8 | 1.9 | 2.0 |
| EPS (RMB) | 0.92 | 1.47 | 1.66 | 1.92 | 2.17 |
Valuation Metrics
| Metric | FY22E | FY23E | FY24E |
|---|---|---|---|
| PE (x) | 7.6 | 6.6 | 5.8 |
| Current Price (HK$) | 15.48 | - | - |
| Target Price (HK$) | 29.65 | - | - |
| Upside/Downside (%) | +91.6% | - | - |
Risks and Considerations
-
Potential Risks:
- Sino-U.S. trade tensions
- Additional component restrictions or technology bans
- 5G deployment delays
-
Macro Factors:
- China lockdowns impacting economic performance
- Russian-Ukraine conflict increasing material costs
- Supply constraints and worldwide inflation
Analysts and Contact
-
Analysts:
- Lily Yang, Ph.D
- Alex Ng
- Lana Lin
-
Contact Information:
- Lily Yang: (852) 3916 3716 / lilyyang@cmbi.com.hk
- Alex Ng: (852) 3900 0881 / alexng@cmbi.com.hk
- Lana Lin: (852) 3761 8912 / lanalin@cmbi.com.hk
Disclosures
-
Auditor: Ernst & Young
-
Ratings:
- BUY: Potential return of over 15% over next 12 months
- OUTPERFORM: Industry expected to outperform the broad market benchmark
- MARKET-PERFORM: Industry expected to perform in-line with the broad market benchmark
-
Important Notes:
- The report is for informational purposes only and not investment advice.
- CMBIGM does not provide individually tailored investment advice.
- Past performance is not indicative of future results.
- The information is based on publicly available data and may change without notice.
- The firm may have conflicts of interest due to market-making or investment banking relationships.
Regulatory Information
-
Hong Kong:
- CMBIGM is a subsidiary of China Merchants Bank.
- The report is not an offer to buy or sell securities.
-
United Kingdom:
- Only for persons within Article 19(5) or Article 49(2) of the Financial Promotion Order 2005.
-
United States:
- Intended for "major US institutional investors" only.
- Not distributed to other persons.
-
Singapore:
- Distributed by CMBI (Singapore) Pte. Limited (CMBISG), an exempt financial adviser.
- Legal responsibility is limited to the extent required by law.
试读结束,高清完整版pdf/doc/ppt,请点下载